Alzheimer's treatment 'benefits patients with severe disease'

Taking the cholinesterase inhibitor galantamine has been shown for the first time to improve cognitive function in patients with severe Alzheimer's disease, according to UK research.

Currently, the drug is only prescribed to patients with mild to moderate Alzheimer's, and stopped when their condition deteriorates to the severe stage.

For this latest study, the researchers randomly assigned 407 patients with severe Alzheimer's who were living in a nursing home to receive galantamine, 24mg daily, or placebo for six months.

Overall, the researchers found that patients who were given galantamine had improved cognitive function, particularly memory and the ability to carry out motor performance tasks.

However, the carers who were looking after the patients reported that those on galantamine showed no improvement in their ability to undertake everyday tasks, compared with the patients on placebo.

The researchers, from the University of Manchester, said: 'The data shows there are untreated patients with severe Alzheimer's disease in nursing homes who could benefit from starting treatment with galantamine.'

But in an editorial, Dr Martin Farlow, from Indiana University, warned that the 'clinical usefulness of galantamine has still not been proven in this population'.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs demand 'triple lock' on ARRS budgets as unfunded pay rise threatens recruitment

GPs demand 'triple lock' on ARRS budgets as unfunded pay rise threatens recruitment

PCNs will be unable to hire the staff they need to support general practice because...

Medeconomics becomes GP Business

Medeconomics becomes GP Business

Our relaunched site, GP Business, supports best practice in finance, management and...

GP to complete COVID-19 boosters in care homes by 1 November

GP to complete COVID-19 boosters in care homes by 1 November

GP-led COVID-19 vaccination sites have been told to prioritise booster jabs for patients...

NHS aims to vaccinate most 12- to 15-year-olds against COVID-19 by October half term

NHS aims to vaccinate most 12- to 15-year-olds against COVID-19 by October half term

NHS England is aiming to administer COVID-19 vaccines to most 12- to 15-year-olds...

BMA demands ‘immediate QOF suspension’ as GPs prepare for booster campaign

BMA demands ‘immediate QOF suspension’ as GPs prepare for booster campaign

The BMA has called for an 'immediate suspension' of QOF with income protection to...

'Out of touch' Javid deepens rift with GPs over face-to-face appointments

'Out of touch' Javid deepens rift with GPs over face-to-face appointments

GP leaders have accused Sajid Javid of being out of touch with reality after he told...